Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 12, 2022

SELL
$0.72 - $1.2 $7,488 - $12,480
-10,400 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.0 - $1.82 $5,000 - $9,100
-5,000 Reduced 32.47%
10,400 $11,000
Q3 2021

Nov 10, 2021

BUY
$1.53 - $1.85 $6,426 - $7,770
4,200 Added 37.5%
15,400 $9,000
Q2 2021

Aug 11, 2021

BUY
$1.55 - $2.15 $17,360 - $24,080
11,200 New
11,200 $6,000

Others Institutions Holding NAVB

About NAVIDEA BIOPHARMACEUTICALS, INC.


  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.